Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0016020 | membrane | 2 | 4 |
Related structures:
AlphaFold database: Q4Q4U3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 87 | 93 | PF00089 | 0.376 |
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.380 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.369 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.467 |
CLV_PCSK_PC1ET2_1 | 172 | 174 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 160 | 164 | PF00082 | 0.421 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.408 |
DOC_CKS1_1 | 223 | 228 | PF01111 | 0.684 |
DOC_CYCLIN_RxL_1 | 140 | 151 | PF00134 | 0.595 |
DOC_CYCLIN_RxL_1 | 156 | 167 | PF00134 | 0.607 |
DOC_WW_Pin1_4 | 222 | 227 | PF00397 | 0.669 |
DOC_WW_Pin1_4 | 5 | 10 | PF00397 | 0.571 |
LIG_14-3-3_CanoR_1 | 160 | 170 | PF00244 | 0.601 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.535 |
LIG_BRCT_BRCA1_1 | 87 | 91 | PF00533 | 0.445 |
LIG_EH1_1 | 155 | 163 | PF00400 | 0.583 |
LIG_eIF4E_1 | 42 | 48 | PF01652 | 0.460 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.652 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.721 |
LIG_FHA_2 | 178 | 184 | PF00498 | 0.642 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.382 |
LIG_GLEBS_BUB3_1 | 57 | 65 | PF00400 | 0.445 |
LIG_LIR_Gen_1 | 130 | 141 | PF02991 | 0.540 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.536 |
LIG_SH2_CRK | 133 | 137 | PF00017 | 0.571 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.384 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.418 |
LIG_SH3_3 | 220 | 226 | PF00018 | 0.664 |
LIG_SH3_3 | 96 | 102 | PF00018 | 0.652 |
LIG_SUMO_SIM_par_1 | 142 | 149 | PF11976 | 0.590 |
LIG_TRAF2_1 | 180 | 183 | PF00917 | 0.637 |
LIG_TYR_ITIM | 131 | 136 | PF00017 | 0.552 |
LIG_WRC_WIRS_1 | 71 | 76 | PF05994 | 0.363 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.589 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.640 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.551 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.644 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.430 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.488 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.715 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.704 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.508 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.549 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.687 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.655 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.417 |
MOD_N-GLC_1 | 152 | 157 | PF02516 | 0.390 |
MOD_N-GLC_1 | 197 | 202 | PF02516 | 0.456 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.588 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.537 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.590 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.656 |
MOD_PIKK_1 | 161 | 167 | PF00454 | 0.588 |
MOD_PIKK_1 | 202 | 208 | PF00454 | 0.736 |
MOD_PIKK_1 | 234 | 240 | PF00454 | 0.802 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.701 |
MOD_PKA_2 | 149 | 155 | PF00069 | 0.660 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.700 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.589 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.607 |
MOD_ProDKin_1 | 222 | 228 | PF00069 | 0.669 |
MOD_ProDKin_1 | 5 | 11 | PF00069 | 0.573 |
TRG_DiLeu_BaEn_1 | 61 | 66 | PF01217 | 0.437 |
TRG_DiLeu_BaEn_3 | 182 | 188 | PF01217 | 0.574 |
TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.556 |
TRG_ENDOCYTIC_2 | 232 | 235 | PF00928 | 0.686 |
TRG_ER_diArg_1 | 158 | 160 | PF00400 | 0.582 |
TRG_NES_CRM1_1 | 22 | 36 | PF08389 | 0.451 |
TRG_Pf-PMV_PEXEL_1 | 143 | 148 | PF00026 | 0.371 |
TRG_Pf-PMV_PEXEL_1 | 186 | 190 | PF00026 | 0.492 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIX5 | Leptomonas seymouri | 86% | 100% |
A0A0S4J8L9 | Bodo saltans | 54% | 100% |
A0A1X0NRU5 | Trypanosomatidae | 66% | 100% |
A0A3Q8IGH3 | Leishmania donovani | 98% | 100% |
A0A422P2X7 | Trypanosoma rangeli | 64% | 100% |
A4HKX4 | Leishmania braziliensis | 90% | 100% |
A4I8F4 | Leishmania infantum | 98% | 100% |
D0AAR7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
E9B3B2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
V5BVM8 | Trypanosoma cruzi | 67% | 100% |